Breaking News

Merck KGaA, Maker of Erbitux Cancer Drug, to Acquire Sigma-Aldrich for $17 Billion
Tweet TWEET

CITADEL CAPITAL 2Q FINANCIAL RESULTS: STATEMENT

     (The following press release from Citadel Capital was received by e-mail. 
It was not confirmed by the sender.)
 
 
Press spacebar to pause and continue. Press esc to stop.